Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

½ÇÇèÀû ¹Ì¸¸¼º ³ú Ãà»è¼Õ»ó¿¡¼­ MethylprednisoloneÀÇ ¿ë·®¿¡ µû¸¥ È¿°ú Evaluation of Methylprednisolone Dosing Regimen in Experimental Diffuse Brain Injury

´ëÇѽŰæ¿Ü°úÇÐȸÁö 1998³â 27±Ç 6È£ p.715 ~ 720
±è±âÂù, ÀÓÁ¾ÇÑ, Çöµ¿±Ù, ½ÅÁ¤ÈÆ,
¼Ò¼Ó »ó¼¼Á¤º¸
±è±âÂù (  ) 
ÀÎÇÏ´ëÇб³ ÀÇ°ú´ëÇÐ ½Å°æ¿Ü°úÇб³½Ç

ÀÓÁ¾ÇÑ (  ) 
ÀÎÇÏ´ëÇб³ ÀÇ°ú´ëÇÐ ½Å°æ¿Ü°úÇб³½Ç
Çöµ¿±Ù (  ) 
ÀÎÇÏ´ëÇб³ ÀÇ°ú´ëÇÐ ½Å°æ¿Ü°úÇб³½Ç
½ÅÁ¤ÈÆ (  ) 
ÀÎÇÏ´ëÇб³ ÀÇ°ú´ëÇÐ ½Å°æ¿Ü°úÇб³½Ç

Abstract

°á ·Ð
¹é¼­¿¡ ´ëÇÑ ½ÇÇèÀû Áߵ ¹Ì¸¸¼º ³ú¼Õ»ó ¸ðµ¨¿¡ ´ëÇÏ¿© °í¿ë·®ÀÇ methylprednisolone¸¦
Åõ¿©ÇÏ¿© ³úºÎÁ¾°ú ¿ë·®¿¡ µû¸¥ È¿°ú¸¦ ¼öºÐÇÔ·®À» ÅëÇÏ¿© ¿¬±¸ÇÏ¿´´Ù. º» ¿¬±¸¿¡¼­
methylprednisoloneÀ» 15§·/§¸, 30§·/§¸, 40§·/§¸¸¦ Åõ¿©ÇßÀ» ¶§´Â ³úºÎÁ¾À» ¾ïÁ¦ÇÏ´Â È¿°ú°¡
Åë°èÇÐÀû À¯ÀǼºÀ» º¸¿´Áö¸¸ 60mg/kgÀ» Åõ¿©ÇÑ °æ¿ì´Â Åë°èÇÐÀû À¯ÀǼºÀ» º¸ÀÌÁö ¾Ê¾Ò´Ù.
ÀÌ´Â methylprednisoloneÀÇ ÀÌ»óÀÛ¿ë(biphasic action)¿¡ ÀÇÇÑ °á°ú·Î »ý°¢µÇ¸ç, ´õ ±ä ÃßÀû
°Ë»ç ±â°£À» °¡Áö°í ½ÇÁ¦ È¿°ú¸¦ °ËÁõÇÏ´Â ¿¬±¸°¡ ÇÊ¿äÇÏ´Ù°í »ç·áµÈ´Ù.
#ÃÊ·Ï#
The present study was undertaken the ability of a single large intraperitioneal dose of
methylprednisolone(15, 30, 40, 60 §·/§¸) to modify the evolution of diffuse brain
injury(DBI) in rats undergoing a contusion injury of 400gm-1m. Twenty five
Spragus-Dawlsy rats wars divided to five groups. Group 1 was not and the water
content of the wools brain wens measured.
When the water content was assamed as the criterion ol brain edema, there was
significant diffrence bstween its effact is biphasic in that the 6§·/§¸ msthylprednisolone
dose is ineffsctive..

Å°¿öµå

Diffuse brain injury; Methylprsdnisolone; Megadose;

¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸

 

µîÀçÀú³Î Á¤º¸

KoreaMed
KAMS